Search research articles
Contact Us
Filters
Showing results (251-260 of 312) with videos related to
Page
of 32
Sort By:
Nature
|
November 17, 1983
A polymorphic DNA marker genetically linked to Huntington's disease
J F Gusella, N S Wexler, P M Conneally, et al.
The American Naturalist
|
November 17, 2006
Directional changes in ecological communities and social-ecological systems: a framework for prediction based on Alaskan examples
F Stuart Chapin, Martin D Robards, Henry P Huntington, et al.
Transplantation
|
June 5, 2020
A Propensity Score-weighted Comparison of Outcomes Between Living and Standard Criteria Deceased Donor Kidney Transplant Recipients
Seychelle Yohanna, Kyla L Naylor, Eric McArthur, et al.
Transplantation
|
March 18, 2016
The Risk of Cardiovascular Disease Is Not Increasing Over Time Despite Aging and Higher Comorbidity Burden of Kidney Transplant Recipients
Ngan N Lam, S Joseph Kim, Gregory A Knoll, et al.
Canadian Journal of Kidney Health and Disease
|
October 11, 2018
Predicting 3-Year Survival in Patients Receiving Maintenance Dialysis: An External Validation of iChoose Kidney in Ontario, Canada
Vivian S Tan, Amit X Garg, Eric McArthur, et al.
The Journal of Urology
|
August 18, 2009
Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis
Joke Beuten, Dawn Garcia, Timothy C Brand, et al.
World Journal of Transplantation
|
July 1, 2016
Risk factors for fracture in adult kidney transplant recipients
Kyla L Naylor, Guangyong Zou, William D Leslie, et al.
Genomics
|
February 15, 1996
Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer
R H Xiang, C H Hensel, D K Garcia, et al.
Journal of the National Cancer Institute
|
September 4, 2003
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial)
David P Dearnaley, Matthew R Sydes, Malcolm D Mason, et al.
Canadian Journal of Kidney Health and Disease
|
January 19, 2016
Frequency of bone mineral density testing in adult kidney transplant recipients from Ontario, Canada: a population-based cohort study
Kyla L Naylor, Guangyong Zou, William D Leslie, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 312) with videos related to
Sort By:
Page
of 32
Nature
|
November 17, 1983
A polymorphic DNA marker genetically linked to Huntington's disease
J F Gusella, N S Wexler, P M Conneally, et al.
The American Naturalist
|
November 17, 2006
Directional changes in ecological communities and social-ecological systems: a framework for prediction based on Alaskan examples
F Stuart Chapin, Martin D Robards, Henry P Huntington, et al.
Transplantation
|
June 5, 2020
A Propensity Score-weighted Comparison of Outcomes Between Living and Standard Criteria Deceased Donor Kidney Transplant Recipients
Seychelle Yohanna, Kyla L Naylor, Eric McArthur, et al.
Transplantation
|
March 18, 2016
The Risk of Cardiovascular Disease Is Not Increasing Over Time Despite Aging and Higher Comorbidity Burden of Kidney Transplant Recipients
Ngan N Lam, S Joseph Kim, Gregory A Knoll, et al.
Canadian Journal of Kidney Health and Disease
|
October 11, 2018
Predicting 3-Year Survival in Patients Receiving Maintenance Dialysis: An External Validation of iChoose Kidney in Ontario, Canada
Vivian S Tan, Amit X Garg, Eric McArthur, et al.
The Journal of Urology
|
August 18, 2009
Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis
Joke Beuten, Dawn Garcia, Timothy C Brand, et al.
World Journal of Transplantation
|
July 1, 2016
Risk factors for fracture in adult kidney transplant recipients
Kyla L Naylor, Guangyong Zou, William D Leslie, et al.
Genomics
|
February 15, 1996
Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer
R H Xiang, C H Hensel, D K Garcia, et al.
Journal of the National Cancer Institute
|
September 4, 2003
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial)
David P Dearnaley, Matthew R Sydes, Malcolm D Mason, et al.
Canadian Journal of Kidney Health and Disease
|
January 19, 2016
Frequency of bone mineral density testing in adult kidney transplant recipients from Ontario, Canada: a population-based cohort study
Kyla L Naylor, Guangyong Zou, William D Leslie, et al.
Page
of 32